Etiproston
Spezifikationen
59619-81-7CAS-Nummer
641-757-2EG-Nummer
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]hept-5-enoic acidIUPAC-Name
C24H32O7Chemische Formel
432.5 g/molMolekulargewicht
Etiproston; 59619-81-7; Etiprostone; Etiprostonum; Prostavet; TCU22W0APY; DTXSID501024232; (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)vinyl)cyclopentyl)-5-heptenoic acid; RefChem:139254; DTXCID401508477; Etiproston [INN]; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]hept-5-enoic acid; Etiproston (INN); Etiprostone [INN-French]; UNII-TCU22W0APY; Etiprostonum [INN-Latin]; BRN 1274276; ETIPROSTON [MI]; Prostavet [veterinary] (TN); CHEMBL2104285; SCHEMBL11602088; BPALXSWPHQNCAA-RLJNYRALSA-N; 15-Deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-pgf2-alpha; 15-Deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-prostaglandin F2-alpha; D07932; Q27289904; 15-Deoxy-15, 15-Ethylenedioxy-16-Phenoxy-Omega-Tetranor PGF-2alpha; 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)ethenyl)cyclopentyl)-, (1R-(1-alpha(Z),2-beta(E),3-alpha,5-alpha))-; Etiproston; 5-Heptenoic acid, 7-[3,5-dihydroxy-2-[2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]-, [1R-[1a(Z),2ss(E),3a,5a]]-; (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]-5-heptenoic acid; EtiproSynonyme
